Skip to content

Arovella Therapeutics Ltd Price, Chart & Factor Analysis

Free Data & Analytics Access
Arovella Therapeutics Ltd · E.ALA.AU · Australia
Use symbol E.ALA.AU in our API & Excel add-in to retrieve this data ↓
0.05
(-0.08%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -100%
Trend -100%
Bubble Risk LOW
Realised Volatility (20D) 44.09%

Arovella Therapeutics Ltd Forecast

Arovella Therapeutics Ltd short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 44.1% a year, a typical one-standard-deviation range is 0.0422–0.0478 over a week, 0.0393–0.0507 over a month and 0.0252–0.0648 over a year. (Signals as of 21 Nov 2026.)

Arovella Therapeutics Ltd Price Chart

MacroFinance.ai

Arovella Therapeutics Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Arovella Therapeutics Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Arovella Therapeutics Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Arovella Therapeutics Ltd
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Arovella Therapeutics Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Arovella Therapeutics Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Arovella Therapeutics Ltd Trading Strategies

31 backtested tactical asset allocation strategies hold EFA (developed markets outside the US), the closest tradable exposure to Arovella Therapeutics Ltd; 22 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 31 strategies holding EFA →

Statistical Distribution of Returns

Plus

How Arovella Therapeutics Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Arovella Therapeutics Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Arovella Therapeutics Ltd (Australia)

Arovella Therapeutics Ltd is a listed security in Australia. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on AltaGas Ltd

Frequently asked questions

What is Arovella Therapeutics Ltd?
Arovella Therapeutics Ltd is a listed security in Australia. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Arovella Therapeutics Ltd price?
The latest close is 0.045 (21 Nov 2026), -0.08% on the day. The price at the top of the page refreshes during the trading day.
Is Arovella Therapeutics Ltd in an uptrend?
As of 21 Nov 2026, short-term momentum is strongly negative (0 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (0 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Arovella Therapeutics Ltd?
20-day realised volatility is 44.1% a year (21 Nov 2026), which implies a typical one-standard-deviation move of about 12.7% over a month and 6.2% over a week.
What factors affect Arovella Therapeutics Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Arovella Therapeutics Ltd, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Arovella Therapeutics Ltd?
31 backtested tactical asset allocation strategies trade Arovella Therapeutics Ltd through EFA; 22 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Arovella Therapeutics Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of Arovella Therapeutics Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Arovella Therapeutics Ltd historical data?
In the Free historical data section of this page: the last 10 years of Arovella Therapeutics Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Arovella Therapeutics Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Arovella Therapeutics Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ALA.AU&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-200.045
2026-11-190.049
2026-11-180.05
2026-11-170.05
2026-11-160.049
2026-11-130.049
2026-11-120.049
2026-11-110.051
2026-11-100.05
2026-11-090.05
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.